Colitogenic CD4+ effector-memory T cells
β
Takayuki Tomita; Takanori Kanai; Yasuhiro Nemoto; Toshimitsu Fujii; Kengo Nozaki
π
Article
π
2008
π
John Wiley and Sons
π
English
β 553 KB
Background: Although the clinical usefulness of leukocytapheresis for patients with inflammatory bowel disease (IBD) has been reported as a selective removal therapy targeting pathogenic immune cells in blood circulation, it remains unclear whether colitogenic CD4 Ο© T cells continuously recirculate